Glucose-Lowering Therapies for Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus: State-Of-The-Art Review
Mayo Clinic Proceedings - Netherlands
doi 10.1016/j.mayocp.2018.07.018
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 1, 2018
Authors
Publisher
Elsevier BV